跳至主要内容
临床试验/CTRI/2025/09/094876
CTRI/2025/09/094876尚未招募不适用

COMPARATIVE EVALUATION OF AGNIKARMA AND SHIVA GUGGULU IN GRIDHRASI (SCIATICA)

Uttarakhand Ayurved university1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2025年9月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
34
试验地点
1
主要终点
Outcome will be measured with the parameters

研究概览

简要总结

Gridhrasi is one of the eighty Vata-nanatmaj Vyadhi which is characterized by onset of Ruka, Toda, Stambha, Spandana initially in Sphika (buttock) and then radiating distally to posterior aspect of Kati (waist), Pristha (back), Uru (thigh), Janu (knee), Jangha (calf) up to Pada (foot).

  • It can be correlated with Sciatica due to its similarities in symptoms between them.

  • Sciatica is nerve pain and numbness from an injury or irritation to the sciatic nerve, which originates in buttock/ gluteal area.

  • Irritation of 4th and 5th lumbar and 1st sacral roots, which form the sciatic nerve, causes pain that extends mainly down the posterior and anterolateral aspects of leg and into the foot termed sciatica.

Agnikarma - Acharya Sushruta has mentioned that Agnikarma Chikitsa is the best treatment amongst all other treatments as once the disease is cured with Agnikarma Chikitsa, it does not recur again.

Aim - To compare the efficacy of Agnikarma and Shiva Guggulu(orally) in the management of Gridhrasi (Sciatica).

Objective 1-To evaluate the effect of Agnikarma by Mrittika Shalaka in management of Gridhrasi (Sciatica)

2-To evaluate the effect of Shiva Guggulu in management of Gridhrasi (Sciatica).

3-To provide a cost effective and safe treatment for the patients of Gridhrasi (Sciatica).

4-To explore the literature regarding Agnikarma and Gridhrasi (Sciatica) in Ayurvedic and modern text

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients who have classical sign and symptoms of Gridhrasi.
  • Patients of age group between 35-70 years.
  • Willingness of patients for study.

排除标准

  • 1.Uncontrolled Hypertension and Diabetes Mellitus.
  • 2.HIV, Hepatitis B and HCV positive.
  • 3.Known Malignancy of spine or other organs.

结局指标

主要结局

Outcome will be measured with the parameters

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

1.Subjective Parameter

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

-Ruka

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

-Stambha

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

-Aruchi

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

-Spandana

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

-Gaurava

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

2.Objective Parameter

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

-SLR Test

时间窗: Outcome will be measured with the parameters | 1.Subjective Parameter | -Ruka | -Stambha | -Aruchi | -Spandana | -Gaurava | 2.Objective Parameter | -SLR Test

次要结局

  • SLR Test(Assessment will be carried out on 14 days interval)

研究者

发起方
Uttarakhand Ayurved university
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Vimal Kumar

Rishikul Ayurvedic College, Uau, Dehradun

研究点 (1)

Loading locations...

相似试验